Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT capsules for IBS-D
NCT02328547Phase 2Completed
- Sponsor
- Montefiore Medical Center
- Start
- May 2015
- Primary completion
- Oct 2017
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic fecal microbiota in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Montefiore Medical Center. Started May 2015; status: completed.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT02328547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02328547.